- November: SSRI CHINA @ CphMRA 2019 conference
Staffs from SSRI CHINA and SSRI headquarters attended the 8th CphMRA (China Pharmaceutical Market Research Association) conference held during October 23rd-25th in Nanjing. There was an attendance of around 300 people, and according to the organizers, around 2/3 of the attendees were from pharmaceutical companies. SSRI CHINA had a booth, participated in a poster session, and Jane Zhang did a presentation about diseases with high unmet needs in China based on the PatientsMap CN 2018 data.
Jane’s presentation explained that hypertension, diabetes, hyperlipidemia and COPD are the top diseases in which Chinese physicians wish for new treatments overall, suggesting that lifestyle diseases are considered as a major social problem in China. However, when looking at more specific conditions that are treated by more specialized doctors, hematologic malignancies, neuro-muscular disorders and psychiatric conditions are considered as diseases with very high unmet needs, suggesting that for specific conditions, there is a high unmet need for innovative and/or orphan drugs, which is similar to that of Western countries. Jane’s presentation received a third-place award out of all 33 presentations.
PatientsMap is a physician survey database product which uncovers the types of diseases that various specialists see, and the monthly patient volume for each disease. The database product is available for 4 countries; Japan, USA, UK and China. PatientsMap China 2018 data is collected from over 10,000 physicians, covering approximately 350 diseases/conditions.
For more details, please refer to the PatientsMap page in our website (above tab); /china/e/patientsmap